https://www.selleckchem.com/products/AZD7762.html
The anxiety and depression scales of the patients decreased after 3 months (p 0.001). PSQI and itssubgroups ratings significantly improved after treatment (p 0.001). Similarly, ISI, ESS, PSAS, and DBAS test scores also improved after treatment (p 0.001). This study provides evidence as to the applicability and acceptability of GON-B in CM treatment in terms of increased sleep quality; improved sleep beliefs, attitudes, and behaviors; and arousals and decreased insomnia findings. This study provides evidence as to the appl
Like
Comment
Share
